These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31965669)

  • 21. Genetic variant rs72613567 of HSD17B13 gene reduces alcohol-related liver disease risk in Chinese Han population.
    Chen H; Zhang Y; Guo T; Yang F; Mao Y; Li L; Liu C; Gao H; Jin Y; Che Y; Li Y; Huang J
    Liver Int; 2020 Sep; 40(9):2194-2202. PubMed ID: 33151633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periodontitis and prevalence of elevated aminotransferases in the Hispanic Community Health Study/Study of Latinos.
    Akinkugbe AA; Barritt AS; Cai J; Offenbacher S; Thyagarajan B; Khambaty T; Singer R; Kallwitz E; Heiss G; Slade GD
    J Periodontol; 2018 Aug; 89(8):949-958. PubMed ID: 29717494
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Kalinowski P; Smyk W; Nowosad M; Paluszkiewicz R; Michałowski Ł; Ziarkiewicz-Wróblewska B; Weber SN; Milkiewicz P; Lammert F; Zieniewicz K; Krawczyk M
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers.
    Stickel F; Lutz P; Buch S; Nischalke HD; Silva I; Rausch V; Fischer J; Weiss KH; Gotthardt D; Rosendahl J; Marot A; Elamly M; Krawczyk M; Casper M; Lammert F; Buckley TWM; McQuillin A; Spengler U; Eyer F; Vogel A; Marhenke S; von Felden J; Wege H; Sharma R; Atkinson S; Franke A; Nehring S; Moser V; Schafmayer C; Spahr L; Lackner C; Stauber RE; Canbay A; Link A; Valenti L; Grove JI; Aithal GP; Marquardt JU; Fateen W; Zopf S; Dufour JF; Trebicka J; Datz C; Deltenre P; Mueller S; Berg T; Hampe J; Morgan MY
    Hepatology; 2020 Jul; 72(1):88-102. PubMed ID: 31630428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
    Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
    J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease.
    Rieman-Klingler MC; Jung J; Tesfai K; Loomba R; Non AL
    Am J Biol Anthropol; 2024 Aug; 184(4):e24979. PubMed ID: 38778456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage.
    Kallwitz ER; Daviglus ML; Allison MA; Emory KT; Zhao L; Kuniholm MH; Chen J; Gouskova N; Pirzada A; Talavera GA; Youngblood ME; Cotler SJ
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):569-76. PubMed ID: 25218670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma.
    Innes H; Morgan MY; Hampe J; Stickel F; Buch S
    Aliment Pharmacol Ther; 2023 Sep; 58(6):623-631. PubMed ID: 37470344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease.
    Liu WY; Eslam M; Zheng KI; Ma HL; Rios RS; Lv MZ; Li G; Tang LJ; Zhu PW; Wang XD; Byrne CD; Targher G; George J; Zheng MH
    J Clin Transl Hepatol; 2021 Apr; 9(2):194-202. PubMed ID: 34007801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms.
    Hudert CA; Adams LA; Alisi A; Anstee QM; Crudele A; Draijer LG; Furse S; Hengstler JG; Jenkins B; Karnebeek K; Kelly DA; Koot BG; Koulman A; Meierhofer D; Melton PE; Mori TA; Snowden SG; van Mourik I; Vreugdenhil A; Wiegand S; Mann JP;
    Hepatol Commun; 2022 Aug; 6(8):1934-1948. PubMed ID: 35411667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.
    Abul-Husn NS; Cheng X; Li AH; Xin Y; Schurmann C; Stevis P; Liu Y; Kozlitina J; Stender S; Wood GC; Stepanchick AN; Still MD; McCarthy S; O'Dushlaine C; Packer JS; Balasubramanian S; Gosalia N; Esopi D; Kim SY; Mukherjee S; Lopez AE; Fuller ED; Penn J; Chu X; Luo JZ; Mirshahi UL; Carey DJ; Still CD; Feldman MD; Small A; Damrauer SM; Rader DJ; Zambrowicz B; Olson W; Murphy AJ; Borecki IB; Shuldiner AR; Reid JG; Overton JD; Yancopoulos GD; Hobbs HH; Cohen JC; Gottesman O; Teslovich TM; Baras A; Mirshahi T; Gromada J; Dewey FE
    N Engl J Med; 2018 Mar; 378(12):1096-1106. PubMed ID: 29562163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
    Serper M; Vujkovic M; Kaplan DE; Carr RM; Lee KM; Shao Q; Miller DR; Reaven PD; Phillips LS; O'Donnell CJ; Meigs JB; Wilson PWF; Vickers-Smith R; Kranzler HR; Justice AC; Gaziano JM; Muralidhar S; Pyarajan S; DuVall SL; Assimes TL; Lee JS; Tsao PS; Rader DJ; Damrauer SM; Lynch JA; Saleheen D; Voight BF; Chang KM;
    PLoS One; 2020; 15(8):e0237430. PubMed ID: 32841307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos.
    Missikpode C; Kramer H; Cotler SJ; Durazo-Arvizu R; Lash JP; Kallwitz E; Cai J; Kuniholm MH; Rosas SE; Ricardo AC; Talavera GA; Raij L; Pirzada A; Daviglus ML
    BMC Nephrol; 2021 Sep; 22(1):302. PubMed ID: 34493216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Genetic Polymorphism in Response to Body Weight Reduction in Japanese Patients with Nonalcoholic Fatty Liver Disease.
    Seko Y; Yamaguchi K; Tochiki N; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Umemura A; Moriguchi M; Itoh Y
    Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients.
    Enomoto H; Aizawa N; Hasegawa K; Ikeda N; Sakai Y; Yoh K; Takata R; Yuri Y; Kishino K; Shimono Y; Ishii N; Takashima T; Nishimura T; Nishikawa H; Iwata Y; Iijima H; Nishiguchi S
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis.
    Beaudoin JJ; Liang T; Tang Q; Banini BA; Shah VH; Sanyal AJ; Chalasani NP; Gawrieh S
    Alcohol Clin Exp Res; 2021 Apr; 45(4):709-719. PubMed ID: 33616244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target.
    Motomura T; Amirneni S; Diaz-Aragon R; Faccioli LAP; Malizio MR; Coard MC; Kocas-Kilicarslan ZN; Frau C; Haep N; Ostrowska A; Florentino RM; Soto-Gutierrez A
    J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34208839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort.
    Wang J; Conti DV; Bogumil D; Sheng X; Noureddin M; Wilkens LR; Le Marchand L; Rosen HR; Haiman CA; Setiawan VW
    Hepatol Commun; 2021 Oct; 5(10):1689-1703. PubMed ID: 34558842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver.
    Alam S; Islam MS; Islam S; Mustafa G; Saleh AA; Ahmad N
    Indian J Gastroenterol; 2017 Sep; 36(5):366-372. PubMed ID: 28975533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
    Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
    BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.